Pain Management Studies Set out to Bring Relief to Seniors

A whopping one-third of Americans -- many of them older adults -- suffer from significant pain that takes a heavy toll on the health care system, the economy, and personal well-being. Yet the problem is largely undertreated. The Gerontological Society of America recently drew attention to this issue in a new publication that offers a blueprint for transforming pain care. GSA is the nation's oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging.

Two studies in GSA's January 2012 "From Publication to Practice" series address the twin issues of pain relief strategies for older adults and the recent FDA labeling changes for acetaminophen.
 
“Taken together, these two new resources will enable the gerontological community to identify opportunities to improve pain management services,” said Cathy Alessi, MD, the 2011 chair of GSA’s Health Sciences Section. “Research indicates that severe pain in older adults leads to a decreased quality of life, including both satisfaction with life and health-related quality of life.”
 
One of the articles, entitled “An Interdisciplinary Look at Advancing Pain Care, Education, and Research: Responding to the IOM’s Call to Action To Improve Pain Management,” not only looks at deficits in assessment and treatment for older adults with pain but also puts forth actionable information for health care providers, researchers, policy makers, educators, caregivers, and patients about a recent Institute of Medicine report, “Relieving Pain in America."  

The other installment in the GSA report, “An Interdisciplinary Look at Labeling Changes for Acetaminophen and the Implications for Patient Care,” was produced in response to the FDA's modifications to the recommended daily dosage of acetaminophen, the hugely popular NSAID over-the-counter pain reliever. Acetaminophen is found in over 600 OTC and prescription medications used by more than 50 million Americans every week to treat symptoms such as pain, fever, and aches. The intent of the FDA changes is reportedly to increase awareness of the presence and amount of acetaminophen in single-ingredient and combination products. The stated goal is to prevent overdoses that can cause acute liver failure.
1 2 Next
Print Article